Evidence map›Paper›PMID 33450869›Full record

ReviewInternational journal of molecular sciences2021

Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer.

Michela Codini, Mercedes Garcia-Gil, Elisabetta Albi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Michela CodiniDepartment of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.ORCID 0000-0002-1562-4495
Mercedes Garcia-GilDepartment of Biology, University of Pisa, 56127 Pisa, Italy.ORCID 0000-0002-1344-2786
Elisabetta AlbiDepartment of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.ORCID 0000-0002-5745-5343
University of Perugia · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid rafts are critical cell membrane lipid platforms enriched in sphingolipid and cholesterol content involved in diverse cellular processes. They have been proposed to influence membrane properties and to accommodate receptors within themselves by facilitating their interaction with ligands. Over the past decade, technical advances have improved our understanding of lipid rafts as bioactive structures. In this review, we will cover the more recent findings about cholesterol, sphingolipids and lipid rafts located in cellular and nuclear membranes in cancer. Collectively, the data provide insights on the role of lipid rafts as biomolecular targets in cancer with good perspectives for the development of innovative therapeutic strategies.

Indexed as

AnimalsAntineoplastic AgentsBiomarkers, TumorCell MembraneCholesterolHumansMembrane MicrodomainsMolecular Targeted TherapyNeoplasmsNuclear EnvelopeSphingolipidsAntineoplastic AgentsBiomarkers, TumorCholesterolSphingolipidscancercholesterollipid raftsphingolipidtherapeutic target

Identifiers

PMID33450869
PMCPMC7828315
OpenAlexW3119383206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.